RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockadeMarie‐Julie Nokin, Chiara Ambrogio|Nature Communications|2024Cited by 54
In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAFV600E lung adenocarcinomaMarie‐Julie Nokin, David Santamarı́a|Cell Reports Medicine|2024Cited by 20